David D. Allison - Jul 8, 2022 Form 4 Insider Report for CinCor Pharma, Inc. (CINC)

Role
Director
Signature
/s/ Cathy Rude, Attorney-in-Fact
Stock symbol
CINC
Transactions as of
Jul 8, 2022
Transactions value $
$12,501
Form type
4
Date filed
7/20/2022, 04:44 PM
Previous filing
Jun 17, 2022
Next filing
Oct 12, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CINC Stock Option (Right to Buy) Award $12.5K +881 $14.19 881 Jul 8, 2022 Common Stock 881 $20.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy in lieu of retainer fees of $12,500.